Publications by authors named "Robert P Gale"

32Publications

Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind.

Authors:
Robert P Gale

Adv Cell Gene Ther 2020 May 21:e88. Epub 2020 May 21.

Centre for Haematology Research Department of Immunology and Inflammation Imperial College London London UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acg2.88DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273049PMC
May 2020

Conquest of COVID-19. Publish it to death?

Authors:
Robert P Gale

Br J Haematol 2020 08 7;190(3):358-360. Epub 2020 Jul 7.

Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300746PMC
August 2020

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2 but not CALR mutation.

Leuk Res 2020 03 11;90:106319. Epub 2020 Feb 11.

Laboratory of Biochemistry-Biotechnology and Advanced Diagnosis, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2020.106319DOI Listing
March 2020

DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.

Br J Haematol 2020 Jul 18;190(1):67-78. Epub 2020 Feb 18.

National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16505DOI Listing
July 2020

Prospects for achieving treatment-free remission in chronic myeloid leukaemia.

Br J Haematol 2020 Aug 14;190(3):318-327. Epub 2020 Feb 14.

Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496116PMC
August 2020

Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.

Br J Haematol 2020 03 27;188(5):796-800. Epub 2019 Dec 27.

MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16326DOI Listing
March 2020

Emergency response to radiological and nuclear accidents and incidents.

Br J Haematol 2019 Aug 6. Epub 2019 Aug 6.

Department of Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16138DOI Listing
August 2019

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Br J Haematol 2019 07 5;186(2):352-355. Epub 2019 Mar 5.

MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15830DOI Listing
July 2019

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Leukemia 2018 09 28;32(9):2077-2081. Epub 2018 Jun 28.

Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0199-5DOI Listing
September 2018

Are We Prepared for Nuclear Terrorism?

N Engl J Med 2018 06;378(25):2449-2450

University of Nebraska Medical Center, Omaha, NE

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1805627DOI Listing
June 2018

Are We Prepared for Nuclear Terrorism?

N Engl J Med 2018 Mar;378(13):1246-1254

From the Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London (R.P.G.); and the Department of Medicine, Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha (J.O.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsr1714289DOI Listing
March 2018

Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling.

Blood Cancer J 2018 02 26;8(2):24. Epub 2018 Feb 26.

Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0063-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827524PMC
February 2018

Assessment of Minimal Residual Disease in Standard-Risk AML.

N Engl J Med 2016 08;375(6):e9

Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1603847
Publisher Site
http://dx.doi.org/10.1056/NEJMc1603847DOI Listing
August 2016

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.

Exp Hematol 2013 Sep 18;41(9):772-8. Epub 2013 May 18.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769491PMC
September 2013